Ekso Bionics Holdings Inc (EKSO) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1.32 is considered Overvalued compared with the five-year average of -2.93. The fair price of Ekso Bionics Holdings Inc (EKSO) is between 5.25 to 7.50 according to relative valuation method. Compared to the current price of 10.00 USD , Ekso Bionics Holdings Inc By Overvalued By 33.42%.

Relative Value

Fair Zone

5.25-7.50

Current Price：10.00

33.42%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Ekso Bionics Holdings Inc (EKSO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Ekso Bionics Holdings Inc (EKSO) has a current Price-to-Book (P/B) ratio of 2.12. Compared to its 3-year average P/B ratio of 1.23, the current P/B ratio is approximately 73.15% higher. Relative to its 5-year average P/B ratio of 1.35, the current P/B ratio is about 57.77% higher. Ekso Bionics Holdings Inc (EKSO) has a Forward Free Cash Flow (FCF) yield of approximately -33.78%. Compared to its 3-year average FCF yield of -73.18%, the current FCF yield is approximately -53.83% lower. Relative to its 5-year average FCF yield of -59.35%, the current FCF yield is about -43.08% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for EKSO competitors is 1.70, providing a benchmark for relative valuation. Ekso Bionics Holdings Inc Corp (EKSO.O) exhibits a P/S ratio of 1.32, which is -22.02% above the industry average. Given its robust revenue growth of -38.31%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of EKSO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of EKSO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is EKSO currently overvalued or undervalued?

Ekso Bionics Holdings Inc (EKSO) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1.32 is considered Overvalued compared with the five-year average of -2.93. The fair price of Ekso Bionics Holdings Inc (EKSO) is between 5.25 to 7.50 according to relative valuation method. Compared to the current price of 10.00 USD, Ekso Bionics Holdings Inc is Overvalued By 33.42%.

What is Ekso Bionics Holdings Inc (EKSO) fair value?

EKSO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Ekso Bionics Holdings Inc (EKSO) is between 5.25 to 7.50 according to relative valuation method.

How does EKSO's valuation metrics compare to the industry average?

The average P/S ratio for EKSO's competitors is 1.70, providing a benchmark for relative valuation. Ekso Bionics Holdings Inc Corp (EKSO) exhibits a P/S ratio of 1.32, which is -22.02% above the industry average. Given its robust revenue growth of -38.31%, this premium appears unsustainable.

What is the current P/B ratio for Ekso Bionics Holdings Inc (EKSO) as of Mar 04 2026?

As of Mar 04 2026, Ekso Bionics Holdings Inc (EKSO) has a P/B ratio of 2.12. This indicates that the market values EKSO at 2.12 times its book value.

What is the current FCF Yield for Ekso Bionics Holdings Inc (EKSO) as of Mar 04 2026?

As of Mar 04 2026, Ekso Bionics Holdings Inc (EKSO) has a FCF Yield of -33.78%. This means that for every dollar of Ekso Bionics Holdings Inc's market capitalization, the company generates -33.78 cents in free cash flow.

What is the current Forward P/E ratio for Ekso Bionics Holdings Inc (EKSO) as of Mar 04 2026?

As of Mar 04 2026, Ekso Bionics Holdings Inc (EKSO) has a Forward P/E ratio of -7.00. This means the market is willing to pay $-7.00 for every dollar of Ekso Bionics Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Ekso Bionics Holdings Inc (EKSO) as of Mar 04 2026?

As of Mar 04 2026, Ekso Bionics Holdings Inc (EKSO) has a Forward P/S ratio of 1.32. This means the market is valuing EKSO at $1.32 for every dollar of expected revenue over the next 12 months.

EKSO Valuation